 INCY,  Merck provide updates on their cancer combo  ASCO17
Keytruda first-line treatment meets primary endpoint in study of advanced bladder cancer patients  ASCO17  Merck
 Merck apparently also has an internal Anti-CTLA4 (MK-1308) in development now

 BMY  AZN 
FYI!  BRK  IeP  KO  PeP  CRM  MSFT  fb  TWTR  Apple  GOOG  Google  JPM  BoeingBoeing  MYL  Merck  VRX  AGN  SNAP  ORCL  Ge  GM… 
 Merck ASCO webcast slides:
   
 
 PRGO CEO is Out! As the Pharma Shakeup Continues. Who is Next?  AGN?  VRX  AGN  MYL  Merck  TWTR  Apple  JNJ  GILD… 
Why Array BioPharma Inc. Sank 13.5% in May  ARRY  Merck  PFE
US Market Indexes Lower to Start the Week  Apple  UTX  CAT  CSCO  Boeing  MCD  Merck  PFE 
 TGTX  BLUE  Merck  SUPN  PBYI:

Here Are Winners And Losers From Year’s Biggest Cancer Meeting:


FDA approves Keytruda in 2 bladder cancer indications  Merck  bladder  cancer 
Updated Data from ECHO202 Trial of Incytes Epacadostat in Combination with  Mercks KEYTRUDAÂ... Read more:  Merck
Updated Data From ECHO-202 Trial Of Incyte???s Epacadostat In Combination With  Merck & Co.?... Read more:  Merck
New Data From Phase II I-SPY 2 TRIAL Shows Improved Outcomes With Combination Of  Merck & Co... Read more:  Merck
 Merck Updated Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA® (pembro... Read more:  Merck
F-star &  Merck Agree Up to €1B Deal to Develop Five  Bispecific Anti- cancer Antibodies  immunotherapy
Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick  themotleyfool  stocks  Merck,  BMY,  REGN 
Most of these booths dwarf my apartment, and  Merck's is bigger than most people's houses.  ASCO17 
 Merck to  BMY 
 CELG  Merck  INCY  EXEL  TSRO:

Dow’s Merck ‘Clearly Won’ Vs. Bristol, Roche In Cancer Trials:


 cytr email the company and demand an explanation of why they didn't release a PR today. dhaen cytrx.com  pfe  jnj  mrk  gsk
Missed  LOXO? Who else besides  Merck has an agent that Rxs multiple tumors based on a single Biomarker crossing tumo… 
268 combination trials involve Keytruda and 242 with Opdivo, of which 86 combine Opdivo w/ Yervoy  PDL1  Merck  BMY

 DewDiligence For now on  Merck and  BMY will keep respectable "ongoing" data in-house.  INCY
Merck stands to win even if its cancer-drug partner loses by  MaxNisen via  Gadfly  Merck  LLY 
 AZN  Merck  LLY  CLVS  TSRO:

Tesaro Crashes Despite Beating AstraZeneca With ‘Stronger’ Data:


That  7MM Strategy Failed!  f  BRK  VRX  AGN  MYL  Merck  HLF  IeP  AMZN  MSFT  CRM  IBM  Ge  GM  Boeing  AA  NVS  GSK… 
 Merck Next one to drop?
I'm getting a new pair of glasses soon. Here's a before picture.  vrx  agn  iep  twtr  myl  mrk  amzn  brk  ko  pep… 
 Viagra,  Lyrica among 91 meds to get June price hikes at  PFE  drugprices  pharma  ABBV  AGN  SNY  NVO  Merck  JNJ 
 TSLA Makes a New 52 Week High!  f  BRK  VRX  AGN  MYL  Merck  HLF  IeP  AMZN  MSFT  CRM  IBM  Ge  GM  Boeing  AA  NVS… 
 ABBV,  NVO, Takeda take home honors in  pharma's latest  reputation study  RHHBY  JNJ  GILD  Merck  SNY  LLY 
 Merck Bristol-Myers Squibb: Value Or Value Trap? 
Another Wk.W/ No Job?Painful!  HLF  IeP  BRK  PYPL  VRX  AGN  MYL  Merck  AMZN  GOOG  PYPL  AIG  FCX  SNAP  IBM  Ge… 
 PowerLunch  SullyCNBC  megtirrell Very nice segment on the defective DNA polymerase  Merck cancer target drug
Here's Why Loxo Oncology Soared as Much as 58.5% Today  LOXO  Merck
NOW on  powerlunch  megtirrell w/  Merck's Perlmutter at  ASC017
Herbalife Has Support at  51!  HLF  IeP  BRK  PYPL  VRX  AGN  MYL  Merck  AMZN  GOOG  PYPL  AIG  FCX  SNAP  IBM  Ge… 
megtirrell: Coming up on PowerLunch from  ASCO17:  Merck Research Labs Pres Dr Roger Perlmutter. What do you want to know?
Coming up on  PowerLunch from  ASCO17:  Merck Research Labs Pres Dr Roger Perlmutter. What do you want to know?
 ASCO2017  FDA  UCLA  KITE  JUNO  Merck  AZN  I mean, if you want to follow the countdown until the DCVax update,… 
 DVAX  Merck:

Why Dynavax Technologies Corporation Stock Soared Today:


biOasis to present on Lysosomal Storage Disorders next week. Transcend is a great solution here.  Merck  PFE  BMY  
Why Dynavax Technologies Corporation Stock Soared Today
What happened  DVAX  Merck
 Allergan's  41MM/Q Aczone Revenues in Jepardy As it FIghts Taro's Generic!
 AGN  VRX  MYL  Merck  GILD  GSK  PRGO… 
Dynavax Trial Success Sparks a Double-Digit Jump  DVAX  Merck -
 
 Merck  ASCO17 Updated Data from ECHO-202 Trial of Incyte’s Epacadostat in Combination with Merck’s KEYTRUDA® (Pembro… 
 INCY  Merck  BMY  PFE 
 Merck Incyte Announces Data on Enzyme Inhibitor with Keytruda 
 Merck touts Keytruda bladder benefit post Tecentriq failure  ASCO17  ASCO2017
 asco17 report card 
 LOXO +46%
 JUNO -9%
 BMY -4%
 RHHBY -5%
 GLYC -15%
 BLUE  +4%
 IMDZ -9%
 AGIO -3%
 Merck -1%
 PBYI +9%
 KITE -3%
Merck Top news - Jun 5th, 2017  Merck 
Valeant???  VRX  AGN  MY  Merck  TWTR  KO  PeP  IEP  Google  SNAP  JNJ  GILD  TWX  fb  NIKe  ACAD  BLUE  BRK  ctrv… 
Why Valeant!  VRX  AGN  MY  Merck  TWTR  KO  PeP  IEP  Google  SNAP  JNJ  GILD  TWX  fb  NIKe  ACAD  BLUE  BRK  ctrv… 
 AFMD partners AFM11 w/  PFE and AFM24 w/  Merck in 2017 are my humble predictions.
Why would you want  BMY when study after study  Merck's data is superior to it.
More Buzz on Valeant Selling of PharmaSwiss For  2B. Bought for euro 350 million!
 VRX  AGN  MYL  Merck  TWTR  Apple… 
 LOXO  Merck:

Loxo’s targeted drug helps variety of advanced cancers in small study:


Something going on in NSCLC between  INCY  Merck  BMY. Still no NSCLC data presented for the nivo + epac combo?
 clsn surging 100% on  news !  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg  dvax  clsn  pbyi
 OBMP OncBioMune Pharmaceuticals Inc Continues to Swim in Major Catalysts … …  GILD  IBB  INSY  NVS  PFE  JNJ  Merck
 cvm surging 45% on  FDA news hold likely to be lifted!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg  dvax  clsn  pbyi
 TST!!! 
 hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk  snap  goog  crm  fb  FTC  GNC  IBM
 TST!!! 
 hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk  snap  goog… 
 clsn surging up 85% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick
  REGN  Merck  BMY
 clsn surging up 80% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
After dust settles and profit takers leave.  CELG  BLUE  LOXO  TGTX  Merck  INCY  TSRO  PBYI imho should all trend up today.     Thoughts
Ok, just a review on some of today's new updates  JUNO  TGTX  INCY  Merck  GLYC  BLUE  ASCO17 
 cytr surging back on amazing  ASCO2017 results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg  dvax  clsn
 clsn surging up 70% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
 NWBO  BMY  Merck  AZN  JUNO  KITE  ASCO Dr. Marnix Bosch will update us today on DCVax-L, Info Arm, and Direct.… 
The future is here  asco17  mrk 
Drive home what an amazing job Frazier and Perlmutter have done -- and how lucky they've gotten.  Merck 
Lo's of successes at  asco17  asco2017  loxo  pbyi  kite  nvs  amgn  incy  mrk  Great to see patients desrve the be… 
 clsn surging up 50% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
 ChrisLacoursier  NorthwestBio  kite  juno  amgn  nvs  bmy  mrk  dcvax will disrupt all.  nwbo  blue  celg  sgen… 
 clsn surging up 45% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
 OBMP OncBioMune Pharmaceuticals Inc Continues to Swim in Major Catalysts …  GILD  IBB  INSY  NVS  PFE  JNJ  Merck
They have to because they already lost combo battle in melanoma and lung,  mrk,  incy,  bmy 
Pharmalot.. Pharmalittle.. Good Morning.. Merck & Scotland conspired to trash a study..  pharma  AZN  ABBV  Merck  PFE
 clsn surging up 35% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
Biotech Forum Daily Digest: ASCO Boosts Oncology Concerns. Spotlight On Trevena  DVAX  FOLD  LOXO  Merck  SUPN  TRVN…
Biotech Forum Daily Digest: ASCO Boosts Oncology Concerns. Spotlight On Trevena  DVAX  FOLD  LOXO  Merck  SUPN  TRVN
 clsn surging up 30% on results!  cytr  cvm  pfe  jnj  exas  mrk  gsk  shpg
A lot coming out of  ASCO17 this weekend. Check out  BioPharmaDive for coverage  cancer  Immunooncology  Merck  INCY  RHHBY  AZN
Zoetis Just Hit an All-Time High: Here's Why the Stock Should Go Higher  LLY  Merck  ZTS 
Howland Capital Management LLC Reduces Position in Merck & Co., Inc.  Merck 
Herbalife Guidance Games in Motion  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk  snap  goog… 
 Merck Presents updated overall survival findings from KEYNOTE-024 in the first-line treatment of patients with adva… 
Herbalife Guidance Trickery!  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk  snap  goog  crm… 
Donald L. Hagan LLC Maintains Stake in Merck & Co., Inc.  Merck 
 LOXO  ASCO data cuts across Cancer Organ Geography-for target-as did recently Appvd Genetically Targeted Keytruda (4% of Solid Tumor)  Merck
 Merck Merck and QuantumLeap Healthcare Collaborative announce results from the Phase 2 I-SPY 2 TRIAL investigating … 
Herbalife Hoodwinks on Guidance!  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk  snap  goog… 
 Merck Updated Data from KEYNOTE-024 Show Continued Overall Survival Benefit of Merck’s KEYTRUDA® (pembr... - 
Herbalife With Reduced Earnings & Increased Expenses  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl… 
 LOXO up 32 %  TGTX 15 %  dvax 24 %  INCY  Merck  TSRO no volume 
 ASCO2017 data show 'deepening response' to Incyte's epacadostat/Keytruda combo  INCY  Merck 
Icahn Gets It Wrong Herbalife Cuts Top & Bottom Line  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl… 
 Merck New Data From Phase 2 I-SPY 2 TRIAL Shows Improved Outcomes with Combination of... 
Herbalife Cuts FY Top & Bottom Line Guidance!  hlf  iep  cmg  brk  twtr  aapl  msft  ko  pep  vrx  agn  myl  mrk… 
 Merck:

Merck (Merck) Presents New Data From Phase 2 I-SPY 2 TRIAL …:


 JacobPlieth  EPVantage  RobinDavison2  Soothsayer " Never met a PD-1 inhibitor that I did not like -> the real deal ->  Merck,   BMY  AZN "
 Merck New Data From Phase 2 I-SPY 2 TRIAL Shows Improved Outcomes with Combination of Merck’s KEYTRUDA®... - 
 INCY Updated Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA  ASCO17  Merck
 Merck Up 2.3% Since Earnings Report: Can It Continue?. Read more:  Merck
 Merck "Audacious Bid" for Gastric Ca Appvl w23%  Keytruda ORR in PD-L1+ What's  HALO 45% ORR in HA+ PDA? Harder to Rx 
 Merck  Merck (Merck) Reports 1+ Yr Follow-Up: KEYTRUDA (pembrolizumab) Shows Continued Overall Survival Benefit Over Chemo
 Merck MERCK  & CO INC SAYS IN  KEYNOTE006, KEYTRUDA WAS  DISCONTINUED DUE TO  ADVERSE REACTIONS IN 9% OF 555 PATIENTS WITH ADVANCED MELANOMA
 Merck:

New Data From Phase 2 I-SPY 2 TRIAL Shows Improved Outcomes …:


 Merck  Merck  INCY Updated Data from ECHO-202 Trial of Incyte’s Epacadostat in Combination with Merck’s KEYTRUDA® 
 INCY  Merck:

Updated Data from ECHO-202 Trial of Incyte’s Epacadostat in …:


BMO  INCY Epacadostat Exceeds Expectations, Raising PT to  166-raising our peak sales estimate for epacadostat to  5bn from  4bn  Merck
 _B_I_O_T_E_C_H_ CS looking for  Merck strength  BMY weakness out of  ASCO17 
 Merck:

Merck (Merck) Reports 1+ Year Follow-Up on KEYTRUDA …:


 Merck:

Merck (Merck) Announces New Monotherapy Data for KEYTRUDA …:


 Merck Presents new data from KEYTRUDA in heavily pre-treated patients with advanced gastric cancer; showed ORR of 1… 
This Enzyme Is the New Focus for Cancer Treatment  IDO   INCY  Merck  NLNK  ASCO17
 Merck Presents one-year follow-up for KEYTRUDA showing continued overall survival benefit over chemotherapy 
One hour away:  cnbc  megtirrell  ASCO17 coverage kicks off 730amET  SquawkCNBC. Hear exclusively fr  RHHBY. Later:  LOXO,  Merck,  INCY, more
Steve Scala publishes his thoughts on big cap pharma data presented over the weekend at  ASCO17  LLY  Merck  BMY  AZN
megtirrell: Good morning  ASCO17! We are live from Chicago all day starting on SquawkCNBC. Talking w  CELG Roche  BMY  JUNO  LOXO  Merck  INC…
Donald L. Hagan LLC Maintains Stake in Merck & Co., Inc.  Merck  stocks
Washington Trust Bank Buys 3,563 Shares of Merck & Co., Inc.  Merck  stocks
Reilly Financial Advisors LLC Boosts Position in Merck & Co., Inc.  Merck 
Washington Trust Bank Buys 3,563 Shares of Merck & Co., Inc.  Merck 
Good morning  ASCO17! We are live from Chicago all day starting on  SquawkCNBC. Talking w  CELG Roche  BMY  JUNO  LOXO  Merck  INCY  BLUE
 Merck Merck (Merck) Up 2.3% Since Earnings Report: Can It Continue? 
 Adaptimmune Therapeutics  ADAP

 GILD  GWPH  CARA  NH  JNJ  Merck  BMY  PFE  SNY  LLY  BoeingYRY  RHHBY  ABBV  BIIB… 
 Merck: Merck presents one-year follow-up for KEYTRUDA showing continued overall survival benefit over chemotherapy 
<< I’ve reviewed the best stock alert services so you don’t have to!  srpt  fb  myl  mrk
 Merck: Merck presents first-time findings from KEYNOTE-164 and KEYNOTE-158 
 Merck: Merck reports follow-up data with KEYTRUDA in combination with Pemetrexed and Carboplatin 
 INCY,  Merck report updated data from cohort of ECHO-202 trial 
Herbalife To Cut Guidance in AM As Expected !  VRX  AgN  MYL  Merck  HD  CAKE  SHAK  JPM  HIIQ  Apple  EXEL  HUN  KO… 
 asco17  asco2017  incy  mrk  iod  loxo all the buzz.  Dont 4get  nwbo  dcvax.  If you rode  jazz  cpxx  icpt  kite… 
 loxo  incy  mrk  bmy  pbmd  ASC017  keytruda finally a checkpoint inhibitor works in  breastcancer 
 asco17  asco2017  incy  mrk  iod  loxo all making waves. Dont 4get  nwbo  dcvax.  If you did  jazz  cpxx  icpt… 
 asco17  asco2017  incy  mrk  iod  loxo all making waves. Dont 4get  nwbo  dcvax.  If you rode  jazz  cpxx  icpt… 
 Amgen  incy  mrk trying to get ahead.   dcvax plays well with others.  Patients deserve the best  amgn  nwbo 
ISI  Merck recently initiated least two new insulins (MK-1092&MK-5160)both glargine comparator arm .novel basal insulin?    NVO  LLY
Herbalife Leaks To CNBC It Will Cut Guidance As New FTC Regulations Take Hold
 HLF  VRX  IeP  Apple  TWTR  MYL  Merck… 
 loxo  incy  mrk  bmy  adamfeuerstein  megtirrell

A checkpoint inhibitor in  breastcancer !


Saw 3 bus stop  Merck  Keytruda ads and a  BMY  Opdivo billboard on the way back from dinner. Yup,  ASCO17 is definitely in town.
Merck & Co.  Merck Receiving Somewhat Positive Media Coverage, Study Finds 
We're LIVE    ASCO17 all day Monday!  megtirrell intvws  RHHBY  CELG  BMY  LOXO  Merck  INCY  BLUE  JUNO  CNBC starting  SquawkCNBC 730amET
